Although prognostic impact of cyclin D1 overexpression on breast carcinoma is controversial, it is worthy to note that overexpression of cyclin D1 is detected in more than 50% of human invasive breast cancers8, and this may be partly due to deregulated proteasomal degradation. Here, CCND1 is linked to breast carcinoma.